Numerai’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.05M Buy
9,288
+3,751
+68% +$1.04M 0.17% 209
2026
Q1
$1.64M Sell
5,537
-7,491
-57% -$2.23M 0.16% 193
2025
Q4
$3.56M Sell
13,028
-1,389
-10% -$377K 0.43% 49
2025
Q3
$3.9M Buy
+14,417
New +$3.92M 0.55% 37
2025
Q1
Sell
-5,173
Closed -$1.2M 505
2024
Q4
$1.2M Sell
5,173
-5,149
-50% -$1.18M 0.33% 101
2024
Q3
$2.28M Buy
10,322
+1,428
+16% +$295K 0.61% 44
2024
Q2
$1.75M Buy
+8,894
New +$1.84M 0.64% 38
2023
Q1
Sell
-15,524
Closed -$2.61M 165
2022
Q4
$2.61M Buy
+15,524
New +$2.7M 1.78% 15

Other funds holding CME

Numerai's CME Position: Q2 2026 in Review

Numerai increased its CME Group (CME) stake by 68% in Q2 2026, buying an estimated $1.04M and bringing the position to 9,288 shares worth $2.05M. The position accounts for 0.17% of the portfolio, ranked #209.

Numerai first reported a position in CME in Q4 2022 and has held it in 8 quarters since. The position peaked at $3.9M in Q3 2025. 1,698 funds tracked by Wall St. Rank hold CME as of Q2 2026.

  • Numerai held 9,288 shares of CME Group worth $2.05M as of Q2 2026.
  • Numerai bought 3,751 CME Group shares in Q2 2026, an estimated $1.04M.
  • CME Group made up 0.17% of Numerai's portfolio in Q2 2026, its #209 holding.
  • Numerai first reported a position in CME Group in Q4 2022 and has held it in 8 quarters since.
  • Numerai's CME Group position peaked at $3.9M in Q3 2025.
  • 1,698 funds tracked by Wall St. Rank held CME Group as of Q2 2026.

Based on Numerai's 13F filing for Q2 2026, filed 14 Aug 2026.